会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明公开
    • New hydroxymacrolide derivatives having immunosuppressive activity
    • 羟基马来酰胺 - 诱导mit免疫抑制剂Wirkung。
    • EP0445975A1
    • 1991-09-11
    • EP91301686.1
    • 1991-02-28
    • MERCK & CO. INC.
    • Bochis, Richard J.Ok, Hyun O.Wyvratt, Matthew J.
    • C07H19/01C07D498/18A61K31/70
    • C07H19/01
    • Novel hydroxymacrolide derivatives of the general structual Formula I:

      have been prepared from (a) suitable precursor(s) by selective reduction of the ketone at C-2. These macrolide immunosuppressants are useful in a human host for the treatment of autoimmune diseases (such as juvenile-onset diabetes melitus, multiple sclerosis and rheumatoid arthritis), infectous diseases and/or the prevention of rejection of foreign organ transplants, e.g. bone marrow and heart transplants.
      In addition, these macrolide immunosuppressants are useful in the topical treatment of inflammatory and hyperproliferative skin diseases and cutaneous manifestations of immunologically-mediated illnesses such as: psoriasis, atopical dermatitiis, contact dermatitis and further eczematous dermatitises, seborrhoeic dermatitis, Lichen planus, Pemphigus, bullous Pemphigoid, Epidermolysis bullosa, urticaria, angioedemas, vasculitides, erythemas, cutaneous eosinophilias, Lupus erythematosus or Alopecia areata.
    • 已经通过在C-2上选择性还原酮从(a)合适的前体制备了一般结构式I的新羟基麦角酰胺衍生物:。 这些大环内酯类免疫抑制剂可用于人宿主中用于治疗自身免疫性疾病(如幼年型糖尿病,多发性硬化和类风湿性关节炎),感染性疾病和/或预防外来器官移植排斥反应。 骨髓和心脏移植。 此外,这些大环内酯类免疫抑制剂可用于局部治疗炎性和过度增生性皮肤病以及免疫介导疾病的皮肤表现,如牛皮癣,特应性皮肤病,接触性皮炎和进一步湿疹性皮肤病,脂溢性皮炎,扁平苔藓,天疱疮,大疱 类天疱疮,大疱表皮松解症,荨麻疹,血管瘤,血管炎,红斑,皮肤嗜酸粒细胞,红斑狼疮或斑秃。